AVXL — Anavex Life Sciences Share News
0.000.00%
Last trade - 00:00- $106.60m
- -$11.72m
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board
Brief: Anavex Life Sciences Regains Compliance With Nasdaq Periodic Filing Requirement
Brief: Anavex Life Sciences Highlights Highly Qualified Board And Decisive Actions To Create Long-Term Value For Stockholders
Anavex Life Sciences Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anavex Life Sciences Announces Plans To Refresh Board To Continue Overseeing Critical Progress And Stockholder Value Creation
Anavex Life Sciences Corp reports results for the quarter ended March 31 - Earnings Summary
Corrected: Anavex Life Sciences Q2 net loss narrows on lower R&D costs
Brief: Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification
U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
U.S. STOCKS ON THE MOVE-DaVita, Knight-Swift, Madrigal Pharma
Anavex slips after board ousts decade‑long CEO for cause
U.S. STOCKS ON THE MOVE-BlackRock, MDA Space, Revolution Medicines
U.S. STOCKS ON THE MOVE-Bloom, J&J, CarMax
U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere
Anavex rises after it plans trials for Alzheimer's, autism drug
Brief: Anavex Life Sciences Provides Comprehensive Regulatory Update